[Nimotuzumab in combination with chemotherapy in patients with advanced non-small cell lung cancer].Safety and efficacy of nimotuzumab with concurrent chemoradiotherapy in unresectable locally advanced squamous cell carcinoma of head and neck: An Indian rural hospital experienceEffectiveness and tolerability of nimotuzumab in unresectable, locally advanced/metastatic esophageal cancer: Indian hospital-based retrospective evidenceEfficacy and safety of concurrent chemoradiotherapy with or without Nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and neck: Prospective comparative study - ESCORT-N studyNimotuzumab Plus Paclitaxel and Cisplatin as a 1-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Nimotuzumab
@en
Nimotuzumab
@fr
Nimotuzumab
@it
Nimotuzumab
@nl
Німотузумаб
@uk
نيموتوزوماب
@ar
尼妥珠单抗
@zh
尼妥珠单抗
@zh-cn
尼妥珠单抗
@zh-hans
尼妥珠單抗
@zh-hant
type
label
Nimotuzumab
@en
Nimotuzumab
@fr
Nimotuzumab
@it
Nimotuzumab
@nl
Німотузумаб
@uk
نيموتوزوماب
@ar
尼妥珠单抗
@zh
尼妥珠单抗
@zh-cn
尼妥珠单抗
@zh-hans
尼妥珠單抗
@zh-hant
altLabel
h-R3, BIOMAb EGFR, TheraCIM, тералок
@uk
prefLabel
Nimotuzumab
@en
Nimotuzumab
@fr
Nimotuzumab
@it
Nimotuzumab
@nl
Німотузумаб
@uk
نيموتوزوماب
@ar
尼妥珠单抗
@zh
尼妥珠单抗
@zh-cn
尼妥珠单抗
@zh-hans
尼妥珠單抗
@zh-hant
P31
P486
P6366
P646
P2275
nimotuzumab
@en-gb
P231
828933-51-3
P486
P6366
2776055544
P646
/m/02pp30g
P652
6NS400BXKH